Motivational Interviewing as a Strategy to Improve Adherence in IBD Treatment: An Integrative Review Amidst COVID-19 Disruptions
Abstract
1. Introduction
2. Materials and Methods
2.1. Identification of the Research Question
RQ1: Can Motivational Interviewing improve therapeutic adherence and/or compliance in adult patients with IBD?
2.2. Search Strategy
2.3. Inclusion and Exclusion Criteria
3. Results
3.1. Study Selection
3.2. Quality Appraisal
3.3. Key Characteristics of Included Studies
Authors—Year | Theoretical or Conceptual Underpinning to the Research | Statement of Research Aim/s | Clear Description of Research Setting and Target Population | The Study Design is Appropriate to Address the Stated Research Aim/s | Appropriate Sampling to Address the Research Aim/s | Rationale for Choice of Data Collection Tool/s | The Format and Content of Data Collection Tool is Appropriate to Address the Stated Research Aim/s | Description of Data Collection Procedure | Recruitment Data Provided | Justification for Analytic Method Selected | The Method of Analysis was Appropriate to Answer the Research Aim/s | Evidence that the Research Stakeholders Have been Considered in Research Design or Conduct | Strengths and Limitations Critically Discussed | Total Score (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ramdeen et al., 2014 [52] | 1 | 1 | 2 | 3 | 2 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 13 (33%) |
Wagoner and Kavookjan, 2017 [33] | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | 3 | 36 (92%) |
Antal-Uram, Harsányi and Perczel-Forintos, 2018 [51] | 3 | 3 | 1 | 3 | 2 | 1 | 3 | 1 | 0 | 1 | 2 | 0 | 0 | 20 (51%) |
Authors—Year | Summary of Findings | References |
---|---|---|
Ramdeen et al., 2014 [52] | This case report involves a 27-year-old Caucasian man diagnosed with Crohn’s disease and shows the use of MI in a nonconfrontational manner to increase cooperation and motivation for health-related changes. While the single case report does not demonstrate the method’s effectiveness, a comprehensive understanding of the theories behind MI can empower nurses and physicians to apply this technique in referral settings. | [52] |
Wagoner and Kavookjan, 2017 [33] | This systematic review includes four articles, comprising two randomized controlled trials (RCTs) and two quasi-experimental studies, with a total sample size ranging from 45 to 278 patients aged between 20 and 82 years. Motivational interviewing demonstrates effectiveness in improving health outcomes, particularly in terms of adherence, help-seeking behavior, and perceptions about empathy from healthcare providers, in patients with IBD. Strengths of the study include its comprehensive review of available literature on MI and patients with IBD. However, limitations include the lack of exclusively RCTs. The findings suggest that healthcare providers may benefit from utilizing MI to enhance patient–provider relationships and communication skills, thereby improving patient outcomes in IBD management. | [33] |
Antal-Uram, Harsányi, and Perczel-Forintos, 2018 [51] | This case report examines the role of a psychologist in managing a 21-year-old patient with Crohn’s disease who also presents with psychiatric disorders, including mood dysregulation and avoidant personality disorder. The intervention options explored include low-intensity cognitive behavioral therapy, including motivational interviewing. The results indicate that psychotherapy sessions incorporating motivational interviewing have led to the remission of mental health symptoms, improved drug adherence, and enhanced quality of life for the patient. Recognizing and addressing psychiatric comorbidities can significantly improve adherence to drug treatment and overall quality of life. Interdisciplinary collaboration is essential to ensure a holistic approach to patient care, encompassing biological, psychological, and spiritual dimensions. | [51] |
3.4. Results of the Included Studies
4. Discussions
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Pullen, N.; Gale, J.D. Inflammatory Bowel Disease; Elsevier: Amsterdam, The Netherlands, 2007. [Google Scholar]
- Bernstein, C.N.; Eliakim, A.; Fedail, S.; Fried, M.; Gearry, R.; Goh, K.-L.; Hamid, S.; Khan, A.G.; Khalif, I.; Ng, S.C.; et al. World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015. J. Clin. Gastroenterol. 2016, 50, 803–818. [Google Scholar] [CrossRef]
- Goyette, P.; Labbé, C.; Trinh, T.T.; Xavier, R.J.; Rioux, J.D. Molecular Pathogenesis of Inflammatory Bowel Disease: Genotypes, Phenotypes and Personalized Medicine. Ann. Med. 2007, 39, 177–199. [Google Scholar] [CrossRef]
- Kaplan, G.G.; Windsor, J.W. The Four Epidemiological Stages in the Global Evolution of Inflammatory Bowel Disease. Nat. Rev. Gastroenterol. Hepatol. 2021, 18, 56–66. [Google Scholar] [CrossRef] [PubMed]
- Eugenicos, M.P.; Ferreira, N.B. Psychological Factors Associated with Inflammatory Bowel Disease. Br. Med. Bull. 2021, 138, 16–28. [Google Scholar] [CrossRef] [PubMed]
- Ghosh, S.; Mitchell, R. Impact of Inflammatory Bowel Disease on Quality of Life: Results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) Patient Survey. J. Crohn’s Colitis 2007, 1, 10–20. [Google Scholar] [CrossRef]
- Simeone, S.; Mercuri, C.; Cosco, C.; Bosco, V.; Pagliuso, C.; Doldo, P. Enacted Stigma in Inflammatory Bowel Disease: An Italian Phenomenological Study. Healthcare 2023, 11, 474. [Google Scholar] [CrossRef]
- Seifarth, C.; Kreis, M.E.; Gröne, J. Indications and Specific Surgical Techniques in Crohn’s Disease. Visc. Med. 2015, 31, 273–279. [Google Scholar] [CrossRef]
- Stidham, R.; Higgins, P. Colorectal Cancer in Inflammatory Bowel Disease. Clin. Colon Rectal Surg. 2018, 31, 168–178. [Google Scholar] [CrossRef] [PubMed]
- Casellas, F.; López-Vivancos, J.; Badia, X.; Vilaseca, J.; Malagelada, J.-R. Influence of Inflammatory Bowel Disease on Different Dimensions of Quality of Life. Eur. J. Gastroenterol. Hepatol. 2001, 13, 567–572. [Google Scholar] [CrossRef]
- Sainsbury, A.; Heatley, R.V. Review Article: Psychosocial Factors in the Quality of Life of Patients with Inflammatory Bowel Disease. Aliment. Pharmacol. Ther. 2005, 21, 499–508. [Google Scholar] [CrossRef]
- Pulley, J.; Todd, A.; Flatley, C.; Begun, J. Malnutrition and Quality of Life among Adult Inflammatory Bowel Disease Patients. JGH Open 2020, 4, 454–460. [Google Scholar] [CrossRef] [PubMed]
- Graff, L.A.; Walker, J.R.; Lix, L.; Clara, I.; Rawsthorne, P.; Rogala, L.; Miller, N.; Jakul, L.; McPhail, C.; Ediger, J.; et al. The Relationship of Inflammatory Bowel Disease Type and Activity to Psychological Functioning and Quality of Life. Clin. Gastroenterol. Hepatol. 2006, 4, 1491–1501.e1. [Google Scholar] [CrossRef] [PubMed]
- Knowles, S.R.; Gass, C.; Macrae, F. Illness Perceptions in IBD Influence Psychological Status, Sexual Health and Satisfaction, Body Image and Relational Functioning: A Preliminary Exploration Using Structural Equation Modeling. J. Crohn’s Colitis 2013, 7, e344–e350. [Google Scholar] [CrossRef] [PubMed]
- Wędrychowicz, A. Advances in Nutritional Therapy in Inflammatory Bowel Diseases: Review. World J. Gastroenterol. 2016, 22, 1045. [Google Scholar] [CrossRef] [PubMed]
- Matsuoka, K.; Kobayashi, T.; Ueno, F.; Matsui, T.; Hirai, F.; Inoue, N.; Kato, J.; Kobayashi, K.; Kobayashi, K.; Koganei, K.; et al. Evidence-Based Clinical Practice Guidelines for Inflammatory Bowel Disease. J. Gastroenterol. 2018, 53, 305–353. [Google Scholar] [CrossRef] [PubMed]
- Demirtas, A. The Lived Experiences of People with Inflammatory Bowel Diseases: A Phenomenological Hermeneutic Study. Int. J. Nurs. Pract. 2022, 28, e12946. [Google Scholar] [CrossRef]
- Vitello, A.; Maida, M.; Shahini, E.; Macaluso, F.S.; Orlando, A.; Grova, M.; Ramai, D.; Serviddio, G.; Facciorusso, A. Current Approaches for Monitoring of Patients with Inflammatory Bowel Diseases: A Narrative Review. J. Clin. Med. 2024, 13, 1008. [Google Scholar] [CrossRef]
- Krienke, R. Adherence to Medication. N. Engl. J. Med. 2005, 353, 1972–1974, author reply 1972–1974. [Google Scholar]
- Horne, R.; Parham, R.; Driscoll, R.; Robinson, A. Patients’ Attitudes to Medicines and Adherence to Maintenance Treatment in Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2009, 15, 837–844. [Google Scholar] [CrossRef]
- Gracie, D.J.; Irvine, A.J.; Sood, R.; Mikocka-Walus, A.; Hamlin, P.J.; Ford, A.C. Effect of Psychological Therapy on Disease Activity, Psychological Comorbidity, and Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Lancet Gastroenterol. Hepatol. 2017, 2, 189–199. [Google Scholar] [CrossRef]
- King, K.; McGuinness, S.; Watson, N.; Norton, C.; Chalder, T.; Czuber-Dochan, W. What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials. Patient Prefer Adherence 2023, 17, 3265–3303. [Google Scholar] [CrossRef] [PubMed]
- Chan, W.; Chen, A.; Tiao, D.; Selinger, C.; Leong, R. Medication Adherence in Inflammatory Bowel Disease. Intest. Res. 2017, 15, 434. [Google Scholar] [CrossRef] [PubMed]
- Theodorou-Kanakari, A. Impact of COVID-19 Pandemic on the Healthcare and Psychosocial Well-Being of Patients with Inflammatory Bowel Disease. Ann. Gastroenterol. 2022, 35, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Bischof, G.; Bischof, A.; Rumpf, H.-J. Motivational Interviewing: An Evidence-Based Approach for Use in Medical Practice. Dtsch. Ärztebl. Int. 2021, 118, 109–115. [Google Scholar] [CrossRef] [PubMed]
- Miller, W.R. Motivational Interviewing with Problem Drinkers. Behav. Cogn. Psychother. 1983, 11, 147–172. [Google Scholar] [CrossRef]
- Miller, W.R.; Rollnick, S. Motivational Interviewing: Helping People Change; Guilford Press: New York, NY, USA, 2012; ISBN 978-1-60918-227-4. [Google Scholar]
- Budhwani, H.; Naar, S. Training Providers in Motivational Interviewing to Promote Behavior Change. Pediatr. Clin. N. Am. 2022, 69, 779–794. [Google Scholar] [CrossRef] [PubMed]
- Rollnick, S.; Miller, W.R.; Butler, C.C.; Aloia, M.S. Motivational Interviewing in Health Care: Helping Patients Change Behavior. COPD J. Chronic Obstr. Pulm. Dis. 2008, 5, 203. [Google Scholar] [CrossRef]
- Papus, M.; Dima, A.L.; Viprey, M.; Schott, A.-M.; Schneider, M.P.; Novais, T. Motivational Interviewing to Support Medication Adherence in Adults with Chronic Conditions: Systematic Review of Randomized Controlled Trials. Patient Educ. Couns. 2022, 105, 3186–3203. [Google Scholar] [CrossRef] [PubMed]
- Mocciaro, F.; Di Mitri, R.; Russo, G.; Leone, S.; Quercia, V. Motivational Interviewing in Inflammatory Bowel Disease Patients: A Useful Tool for Outpatient Counselling. Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver 2014, 46, 893–897. [Google Scholar] [CrossRef]
- Miller, W.R.; Rollnick, S. Motivational Interviewing: Preparing People for Change, 2nd ed.; Guilford Press: New York, NY, USA, 2002; ISBN 978-1-57230-563-2. [Google Scholar]
- Wagoner, S.T.; Kavookjian, J. The Influence of Motivational Interviewing on Patients with Inflammatory Bowel Disease: A Systematic Review of the Literature. J. Clin. Med. Res. 2017, 9, 659–666. [Google Scholar] [CrossRef]
- Riccaboni, M.; Verginer, L. The Impact of the COVID-19 Pandemic on Scientific Research in the Life Sciences. PLoS ONE 2022, 17, e0263001. [Google Scholar] [CrossRef] [PubMed]
- Occhipinti, V.; Pastorelli, L. Challenges in the Care of IBD Patients during the CoViD-19 Pandemic: Report From a “Red Zone” Area in Northern Italy. Inflamm. Bowel Dis. 2020, 26, 793–796. [Google Scholar] [CrossRef] [PubMed]
- Kemp, K.; Avery, P.; Bryant, R.; Cross, A.; Danter, K.; Kneebone, A.; Morris, D.; Walker, A.; Whitley, L.; Dibley, L. Clinical Service Delivery Implications of the COVID-19 Pandemic on People with Inflammatory Bowel Disease: A Qualitative Study. BMC Health Serv. Res. 2023, 23, 1195. [Google Scholar] [CrossRef] [PubMed]
- Olmastroni, E.; Galimberti, F.; Tragni, E.; Catapano, A.L.; Casula, M. Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review. Int. J. Environ. Res. Public Health 2023, 20, 3825. [Google Scholar] [CrossRef] [PubMed]
- De Miguel, M.; Doger, B.; Boni, V.; Hernández-Guerrero, T.; Moreno, I.; Morillo, D.; Moreno, V.; Calvo, E. Increased Vulnerability of Clinical Research Units during the COVID-19 Crisis and Their Protection. Cancer 2020, 126, 3907–3911. [Google Scholar] [CrossRef] [PubMed]
- Viganò, C.; Mulinacci, G.; Palermo, A.; Barisani, D.; Pirola, L.; Fichera, M.; Invernizzi, P.; Massironi, S. Impact of COVID-19 on Inflammatory Bowel Disease Practice and Perspectives for the Future. World J. Gastroenterol. 2021, 27, 5520–5535. [Google Scholar] [CrossRef] [PubMed]
- Ungaro, R.C.; Chou, B.; Mo, J.; Ursos, L.; Twardowski, R.; Candela, N.; Colombel, J.-F. Impact of COVID-19 on Healthcare Resource Utilisation among Patients with Inflammatory Bowel Disease in the USA. J. Crohn’s Colitis 2022, 16, 1405–1414. [Google Scholar] [CrossRef] [PubMed]
- Soares, C.B.; Hoga, L.A.K.; Peduzzi, M.; Sangaleti, C.; Yonekura, T.; Silva, D.R.A.D. Integrative Review: Concepts and Methods Used in Nursing. Rev. Esc. Enferm. USP 2014, 48, 335–345. [Google Scholar] [CrossRef] [PubMed]
- Dhollande, S.; Taylor, A.; Meyer, S.; Scott, M. Conducting Integrative Reviews: A Guide for Novice Nursing Researchers. J. Res. Nurs. 2021, 26, 427–438. [Google Scholar] [CrossRef]
- Russell, C.L. An Overview of the Integrative Research Review. Prog. Transplant. 2005, 15, 8–13. [Google Scholar] [CrossRef]
- Whittemore, R.; Knafl, K. The Integrative Review: Updated Methodology. J. Adv. Nurs. 2005, 52, 546–553. [Google Scholar] [CrossRef] [PubMed]
- Souza, M.T.D.; Silva, M.D.D.; Carvalho, R.D. Integrative Review: What Is It? How to Do It? Einstein São Paulo 2010, 8, 102–106. [Google Scholar] [CrossRef]
- Leppäkoski, T.; Paavilainen, E. Triangulation as a Method to Create a Preliminary Model to Identify and Intervene in Intimate Partner Violence. Appl. Nurs. Res. 2012, 25, 171–180. [Google Scholar] [CrossRef] [PubMed]
- Torraco, R.J. Writing Integrative Literature Reviews: Guidelines and Examples. Hum. Resour. Dev. Rev. 2005, 4, 356–367. [Google Scholar] [CrossRef]
- Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef] [PubMed]
- Harrison, R.; Jones, B.; Gardner, P.; Lawton, R. Quality Assessment with Diverse Studies (QuADS): An Appraisal Tool for Methodological and Reporting Quality in Systematic Reviews of Mixed- or Multi-Method Studies. BMC Health Serv. Res. 2021, 21, 144. [Google Scholar] [CrossRef] [PubMed]
- Al-shaari, H.; J, F.; R, M.; CJ, H. A Systematic Review of Repeatability and Reproducibility Studies of Diffusion Tensor Imaging of Cervical Spinal Cord. Br. J. Radiol. 2023, 96, 20221019. [Google Scholar] [CrossRef] [PubMed]
- Antal-Uram, D.; Harsányi, L.; Perczel-Forintos, D. Az alacsony intenzitású, bizonyítottan hatékony kognitív viselkedésterápia Crohn-betegségben. Orvosi Hetil. 2018, 159, 363–369. [Google Scholar] [CrossRef] [PubMed]
- Ramdeen, M.; Poullis, A.; Gupta, S.; Ghosh, D. Motivational Interviewing to Improve Inflammatory Bowel Disease Outcomes. Gastrointest. Nurs. 2014, 12, 15–22. [Google Scholar] [CrossRef]
- Cook, P.F.; Emiliozzi, S.; El-Hajj, D.; McCabe, M.M. Telephone Nurse Counseling for Medication Adherence in Ulcerative Colitis: A Preliminary Study. Patient Educ. Couns. 2010, 81, 182–186. [Google Scholar] [CrossRef]
- Moshkovska, T.; Stone, M.A.; Smith, R.M.; Bankart, J.; Baker, R.; Mayberry, J.F. Impact of a Tailored Patient Preference Intervention in Adherence to 5-Aminosalicylic Acid Medication in Ulcerative Colitis: Results from an Exploratory Randomized Controlled Trial. Inflamm. Bowel Dis. 2011, 17, 1874–1881. [Google Scholar] [CrossRef] [PubMed]
- Berrill, J.W.; Sadlier, M.; Hood, K.; Green, J.T. Mindfulness-Based Therapy for Inflammatory Bowel Disease Patients with Functional Abdominal Symptoms or High Perceived Stress Levels. J. Crohn’s Colitis 2014, 8, 945–955. [Google Scholar] [CrossRef] [PubMed]
- Schoefs, E.; Vermeire, S.; Ferrante, M.; Sabino, J.; Lambrechts, T.; Avedano, L.; Haaf, I.; De Rocchis, M.S.; Broggi, A.; Sajak-Szczerba, M.; et al. What Are the Unmet Needs and Most Relevant Treatment Outcomes According to Patients with Inflammatory Bowel Disease? A Qualitative Patient Preference Study. J. Crohn’s Colitis. [CrossRef] [PubMed]
- Berger, B.; Villaume, W.A. Motivational Interviewing for Health Care Professionals: A Sensible Approach; American Pharmacists Association: Washington, DC, USA, 2013; ISBN 978-1-58212-180-2. [Google Scholar]
- Zomahoun, H.T.V.; Guénette, L.; Grégoire, J.-P.; Lauzier, S.; Lawani, A.M.; Ferdynus, C.; Huiart, L.; Moisan, J. Effectiveness of Motivational Interviewing Interventions on Medication Adherence in Adults with Chronic Diseases: A Systematic Review and Meta-Analysis. Int. J. Epidemiol. 2016, 46, 589–602. [Google Scholar] [CrossRef] [PubMed]
- Kok, K.B.; Byrne, P.; Ibarra, A.R.; Martin, P.; Rampton, D.S. Understanding and Managing Psychological Disorders in Patients with Inflammatory Bowel Disease: A Practical Guide. Frontline Gastroenterol. 2023, 14, 78–86. [Google Scholar] [CrossRef] [PubMed]
- Lewis, K.; Marrie, R.A.; Bernstein, C.N.; Graff, L.A.; Patten, S.B.; Sareen, J.; Fisk, J.D.; Bolton, J.M. CIHR Team in Defining the Burden and Managing the Effects of Immune-Mediated Inflammatory Disease; Marrie, R.A.; et al. The Prevalence and Risk Factors of Undiagnosed Depression and Anxiety Disorders among Patients with Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2019, 25, 1674–1680. [Google Scholar] [CrossRef] [PubMed]
- Paulides, E.; Boukema, I.; Van Der Woude, C.J.; De Boer, N.K.H. The Effect of Psychotherapy on Quality of Life in IBD Patients: A Systematic Review. Inflamm. Bowel Dis. 2021, 27, 711–724. [Google Scholar] [CrossRef] [PubMed]
- Hughes, S.; Sibelli, A.; Everitt, H.A.; Moss-Morris, R.; Chalder, T.; Harvey, J.M.; Vas Falcao, A.; Landau, S.; O’Reilly, G.; Windgassen, S.; et al. Patients’ Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study. J. Med. Internet Res. 2020, 22, e18691. [Google Scholar] [CrossRef] [PubMed]
- D’Incà, R.; Bertomoro, P.; Mazzocco, K.; Vettorato, M.G.; Rumiati, R.; Sturniolo, G.C. Risk Factors for Non-adherence to Medication in Inflammatory Bowel Disease Patients. Aliment. Pharmacol. Ther. 2008, 27, 166–172. [Google Scholar] [CrossRef]
- Bosworth, H.B.; Fortmann, S.P.; Kuntz, J.; Zullig, L.L.; Mendys, P.; Safford, M.; Phansalkar, S.; Wang, T.; Rumptz, M.H. Recommendations for Providers on Person-Centered Approaches to Assess and Improve Medication Adherence. J. Gen. Intern. Med. 2017, 32, 93–100. [Google Scholar] [CrossRef]
- Gurley, N.; Ebeling, E.; Bennett, A.; Kayembe Kashondo, J.-J.; Ayano Ogawa, V.; Couteau, C.; Felten, C.; Gomanie, N.; Irungu, P.; Shelley, K.; et al. National Policy Responses to Maintain Essential Health Services during the COVID-19 Pandemic. Bull. World Health Organ. 2022, 100, 168–170. [Google Scholar] [CrossRef] [PubMed]
- Wetwittayakhlang, P.; Albader, F.; Golovics, P.A.; Hahn, G.D.; Bessissow, T.; Bitton, A.; Afif, W.; Wild, G.; Lakatos, P.L. Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease. Can. J. Gastroenterol. Hepatol. 2021, 2021, 1–9. [Google Scholar] [CrossRef] [PubMed]
- Harris, R.J.; Downey, L.; Smith, T.R.; Cummings, J.R.F.; Felwick, R.; Gwiggner, M. Life in Lockdown: Experiences of Patients with IBD during COVID-19. BMJ Open Gastroenterol. 2020, 7, e000541. [Google Scholar] [CrossRef] [PubMed]
- Reddy, T.; Kapoor, N.R.; Kubota, S.; Doubova, S.V.; Asai, D.; Mariam, D.H.; Ayele, W.; Mebratie, A.D.; Thermidor, R.; Sapag, J.C.; et al. Associations between the Stringency of COVID-19 Containment Policies and Health Service Disruptions in 10 Countries. BMC Health Serv. Res. 2023, 23, 363. [Google Scholar] [CrossRef] [PubMed]
- Goodsall, T.M.; Han, S.; Bryant, R.V. Understanding Attitudes, Concerns, and Health Behaviors of Patients with Inflammatory Bowel Disease during the Coronavirus Disease 2019 Pandemic. J. Gastroenterol. Hepatol. 2021, 36, 1550–1555. [Google Scholar] [CrossRef] [PubMed]
- Moum, K.M.; Moum, B.; Opheim, R. Patients with Inflammatory Bowel Disease on Immunosuppressive Drugs: Perspectives’ on COVID-19 and Health Care Service during the Pandemic. Scand. J. Gastroenterol. 2021, 56, 545–551. [Google Scholar] [CrossRef] [PubMed]
- Mikhael, E.; Khalife, Y.; Yaghi, C.; Khoury, B.; Khazaka, S.; Khoueiry, C.; Safar, K.; Sayegh, R.B.; Honein, K.; Slim, R. Perception and Attitude of Lebanese IBD Patients during the COVID-19 Pandemic. Patient Prefer Adherence 2023, 17, 1967–1975. [Google Scholar] [CrossRef]
- Bagheri Lankarani, K.; Roozitalab, M.; Gholami, Z.; Yousefi, M.; Ghahramani, S. Inflammatory Bowel Disease during COVID-19 Pandemic: A Prospective Cohort Study of Incidence Rate and Patients’ Concerns. Middle E. J. Dig. Dis. 2022, 14, 24–33. [Google Scholar] [CrossRef]
- Lee, Y.J.; Kim, K.O.; Kim, M.C.; Cho, K.B.; Park, K.S.; Jang, B.I.; on behalf of the Crohn’s and Colitis Association in Daegu-Gyeongbuk (CCAiD). Perceptions and Behaviors of Patients with Inflammatory Bowel Disease during the COVID-19 Crisis. Gut Liver 2022, 16, 81–91. [Google Scholar] [CrossRef]
- Pellegrino, R.; Pellino, G.; Selvaggi, F.; Federico, A.; Romano, M.; Gravina, A.G. Therapeutic Adherence Recorded in the Outpatient Follow-up of Inflammatory Bowel Diseases in a Referral Center: Damages of COVID-19. Dig. Liver Dis. 2022, 54, 1449–1451. [Google Scholar] [CrossRef]
- Ramos, L.; Reygosa, C.; Carrillo-Palau, M.; Alonso-Abreu, I.; González-Mendez, Y.; De La Barreda, R.; Amaral, C.; Hernández, A.; Benítez-Zafra, F.; Hernandez-Guerra, M. Efficacy, Efficiency, and Acceptability of Telemedicine for Inflammatory Bowel Disease Patients’ Follow-Up Care during the COVID-19 Pandemic. Dig. Dis. 2023, 41, 574–580. [Google Scholar] [CrossRef] [PubMed]
- Braun, A.; Portner, J.; Grainger, E.M.; Hill, E.B.; Young, G.S.; Clinton, S.K.; Spees, C.K. Tele-Motivational Interviewing for Cancer Survivors: Feasibility, Preliminary Efficacy, and Lessons Learned. J. Nutr. Educ. Behav. 2018, 50, 19–32.e1. [Google Scholar] [CrossRef] [PubMed]
- Sawaengsri, N.; Maneesriwongul, W.; Schorr, E.; Wangpitipanit, S. Effects of Telephone-Based Brief Motivational Interviewing on Self-Management, Medication Adherence, and Glycemic Control in Patients with Uncontrolled Type 2 Diabetes Mellitus in a Rural Community in Thailand. Patient Prefer Adherence 2023, 17, 2085–2096. [Google Scholar] [CrossRef] [PubMed]
- Dorstyn, D.S.; Mathias, J.L.; Bombardier, C.H.; Osborn, A.J. Motivational Interviewing to Promote Health Outcomes and Behaviour Change in Multiple Sclerosis: A Systematic Review. Clin. Rehabil. 2020, 34, 299–309. [Google Scholar] [CrossRef] [PubMed]
- Lenti, M.V.; Selinger, C.P. Medication Non-Adherence in Adult Patients Affected by Inflammatory Bowel Disease: A Critical Review and Update of the Determining Factors, Consequences and Possible Interventions. Expert Rev. Gastroenterol. Hepatol. 2017, 11, 215–226. [Google Scholar] [CrossRef] [PubMed]
- Shah, R.; Wright, E.; Tambakis, G.; Holmes, J.; Thompson, A.; Connell, W.; Lust, M.; Niewiadomski, O.; Kamm, M.; Basnayake, C.; et al. Telehealth Model of Care for Outpatient Inflammatory Bowel Disease Care in the Setting of the COVID-19 Pandemic. Intern. Med. J. 2021, 51, 1038–1042. [Google Scholar] [CrossRef]
- Perry, J.; Chen, A.; Kariyawasam, V.; Collins, G.; Choong, C.; Teh, W.L.; Mitrev, N.; Kohler, F.; Leong, R.W.L. Medication Non-Adherence in Inflammatory Bowel Diseases Is Associated with Disability. Intest. Res. 2018, 16, 571–578. [Google Scholar] [CrossRef]
- Xue, J.Z.; Smietana, K.; Poda, P.; Webster, K.; Yang, G.; Agrawal, G. Clinical Trial Recovery from COVID-19 Disruption. Nat. Rev. Drug Discov. 2020, 19, 662–663. [Google Scholar] [CrossRef]
Population | Adults with inflammatory bowel disease (IBD) |
Intervention | Motivational interviewing |
Outcome | Improvement of therapeutic adherence or compliance |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mercuri, C.; Catone, M.; Bosco, V.; Guillari, A.; Rea, T.; Doldo, P.; Simeone, S. Motivational Interviewing as a Strategy to Improve Adherence in IBD Treatment: An Integrative Review Amidst COVID-19 Disruptions. Healthcare 2024, 12, 1210. https://doi.org/10.3390/healthcare12121210
Mercuri C, Catone M, Bosco V, Guillari A, Rea T, Doldo P, Simeone S. Motivational Interviewing as a Strategy to Improve Adherence in IBD Treatment: An Integrative Review Amidst COVID-19 Disruptions. Healthcare. 2024; 12(12):1210. https://doi.org/10.3390/healthcare12121210
Chicago/Turabian StyleMercuri, Caterina, Maria Catone, Vincenzo Bosco, Assunta Guillari, Teresa Rea, Patrizia Doldo, and Silvio Simeone. 2024. "Motivational Interviewing as a Strategy to Improve Adherence in IBD Treatment: An Integrative Review Amidst COVID-19 Disruptions" Healthcare 12, no. 12: 1210. https://doi.org/10.3390/healthcare12121210
APA StyleMercuri, C., Catone, M., Bosco, V., Guillari, A., Rea, T., Doldo, P., & Simeone, S. (2024). Motivational Interviewing as a Strategy to Improve Adherence in IBD Treatment: An Integrative Review Amidst COVID-19 Disruptions. Healthcare, 12(12), 1210. https://doi.org/10.3390/healthcare12121210